To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

NCT05101135 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: JT-001
DRUG: JT-001 Placebo

Sponsor

Jeil Pharmaceutical Co., Ltd.